Compliance poor with new oral anticoagulantsOne in three seniors not taking the drugs as directed, Ontario study shows Comparing management strategies for statin-associated muscle symptomsNew Canadian study adds support for considering same-statin rechallenge. Blood pressure rethink may be needed for younger adults Prognostic value of systolic and diastolic readings varies by race and age CT scan offers early window on cardiovascular risk Coronary artery calcium score identifies younger adults in danger of an MI Cancer incidence and mortality rates decreasing in Alberta: new data Study reveals how stress may increase risk of heart disease and stroke Brain’s amygdalar activity ‘robustly’ predicts cardiovascular events, researchers find Your patient has a lower GI bleed on ASA—Do you resume antiplatelet therapy? Study suggests balance favours resumption, to reduce cardiovascular risk Bleeding risk increased with dabigatran-statin combo Study of Ontario seniors suggests caution needed with simvastatin and lovastatin Clinical Feature: Update on managing dyslipidemia A review of the updated Canadian Cardiovascular Society guidelines for dyslipidemia management. Edoxaban (Lixiana) approved in Canada Fourth direct-acting oral anticoagulant expected to reach Canadian market in early 2017. First Previous 33 34 35 36 37 Next Last